INS and type 2 diabetes mellitus: On the other hand, Hanabusa et al., reported similar fasting amylin in T2DM- lean patients on oral hypoglycemic agents and lower fasting amylin in insulin-treated T2DM subjects, along with decreased amylin responses to OGTT compared with healthy controls [189].